Monday, May 20, 2024

Amgen gets FDA approval for small-cell lung-cancer treatment

Must read



Amgen on Thursday received approval from U.S. regulators for its drug to treat a form of late-stage lung-cancer.



Source link

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article